5,5-dimethyl-1-pyrroline-1-oxide has been researched along with sb 203580 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, S; Hasegawa, T; Kirima, K; Kyaw, M; Suzaki, Y; Tamaki, T; Tsuchiya, K; Yoshizumi, M | 1 |
1 other study(ies) available for 5,5-dimethyl-1-pyrroline-1-oxide and sb 203580
Article | Year |
---|---|
Antioxidants inhibit endothelin-1 (1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1).
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Cell Division; Cyclic N-Oxides; DNA; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Onium Compounds; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Pyridines; Rats; Rats, Sprague-Dawley; Time Factors; Transcription Factor AP-1 | 2002 |